First employee of UK Speciality Pharma company, building the business up to over 100 employees
Successfully attained SMC and AWMSG approval for lead product Ferinject®
Initiated growth strategy for Ferinject®, achieving growth of over 30% per annum in 2015, 2016 & 2017 and 25% growth in 2018
Led integration of Vifor Pharma and Vifor Fresenius Medical Care Renal Pharma
Creation of £30 million plus Vifor Pharma UK business from inception